Subscribe to RSS
DOI: 10.1055/a-2127-5751
Re: Bowel Lengthening Procedures in Children with Short Bowel Syndrome: A Systematic Review

Bowel Lengthening Procedures in Children with Short Bowel Syndrome: A Systematic Review
Bowel Lengthening Procedures in Children with Short Bowel Syndrome: A Systematic Review
We thank the author of the letter for raising this valid point with regard to the possibility of multiple counting of patient through inclusion of several studies from the same centers. During the writing of our article,[1] we contacted the corresponding authors of the included studies, if their contact information was provided, with the question to clarify if patients were included in several studies. We did not receive clarification on these enquiries and therefore included all the studies.
Per the suggestion of the author of the letter, we have made a separate analysis excluding all studies from similar centers with complete overlap with regard to the time period studied. Below we present the updated results on the most important outcomes of our systematic review.
Of the original 40 studies, 13 were excluded ([Table 1]). Eleven studies discussed the effects of first the longitudinal intestinal lengthening and tailoring (LILT; a total of 213 of the original 324 patients are described). Eleven studies discussed the effects of the first serial transverse enteroplasty (STEP; a total of 279 of the original 377 patients are described).
Abbreviations: LILT, longitudinal intestinal lengthening and tailoring; re-STEP, repeat STEP; STEP, serial transverse enteroplasty.
With regard to LILT, 56% of patients were completely weaned from parenteral nutrition at the end of follow-up, compared to 52% described in our article with all the included studies.
With regard to STEP, 54% of patients were completely weaned from parenteral nutrition at the end of follow-up, compared to 45% described in our article with all the included studies.
With regard to LILT, 21% of patients had died at the end of follow-up, compared to 26% described in our article with all the included studies.
With regard to STEP, 6% of patients had died at the end of follow-up, compared to 7% described in our article with all the included studies.
These results do not differ greatly from our systematic review. As discussed in our review, we could not compare LILT versus STEP due to incomparability between groups as different time periods are described were supportive care for patient suffering from short bowel syndrome evolved greatly.
As our updated results after exclusion of double patient inclusion due to inclusion of studies from the same centers do not differ greatly, we believe that the conclusion of our article remains valid: “LILT and STEP are both valuable treatment strategies used in the management of pediatric short bowel syndrome. However, currently, it is not possible to advise surgeons on accurate patient selection and to predict the result of either intervention.” Furthermore, this issue further raises the necessity of homogenous, worldwide, prospective outcome reporting to improve the quality of research, and thereby the care, for patients with this rare condition.
Publication History
Received: 30 June 2023
Accepted: 10 July 2023
Accepted Manuscript online:
12 July 2023
Article published online:
30 September 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Nagelkerke SCJ, Poelgeest MYV, Wessel LM. et al; ERNICA Intestinal Failure Working Group. Bowel lengthening procedures in children with short bowel syndrome: a systematic review. Eur J Pediatr Surg 2022; 32 (04) 301-309